Wisconsin's state health plan and GLP-1s
State employees in Wisconsin get GLP-1s for weight loss from January 1, 2027, at $200 a copay. The papers behind that vote are unusually candid about the arithmetic — including one line every cash-pay shopper in the state should read, which is that the cheap direct-from-the-drugmaker prices in the news do not apply to anyone using this plan.
What changed, and what the document says
The vote
CoveredCoverage starts January 1, 2027, for non-Medicare members, at a flat $200 a prescription.
“In addition, the Board approved coverage of AOMs at a separate cost-sharing level for non-Medicare members, effective January 1, 2027. Members will have a $200 copay for these weight-loss drugs.”
Wisconsin Department of Employee Trust Funds — Department News — March 16, 2026
Where the $200 came from
ContextNot a round number somebody liked. It's the ceiling the drugmakers' rebate contracts allow before the rebates start disappearing.
“New Navitus agreements also allow the Board to establish a dedicated formulary tier for AOMs. Under this option, the Board could require a member copay of up to $200 per prescription without risking rebate loss.”
Wisconsin Department of Employee Trust Funds, Office of Strategic Health Policy — Correspondence Memorandum to the Group Insurance Board — February 16, 2026 (Revised)
The same contracts set the BMI rule
Conditions applyTighten who qualifies and the rebates shrink. Tighten past a BMI of 35 and they stop. That's a manufacturer term shaping a public benefit.
“Under current manufacturer agreements, rebates are reduced if the minimum BMI requirement is increased to 35 and end if the BMI requirement is more than 35.”
Wisconsin Department of Employee Trust Funds, Office of Strategic Health Policy — Correspondence Memorandum to the Group Insurance Board — February 16, 2026 (Revised)
What it costs the fund
ContextThe board's actuary priced six years of it before the vote, and the number is not small.
“Segal estimates that covering AOMs with full rebates would cost the Board between $3.5 million and $24.3 million annually over the first six years of coverage (Table 1).”
Wisconsin Department of Employee Trust Funds, Office of Strategic Health Policy — Correspondence Memorandum to the Group Insurance Board — February 16, 2026 (Revised)
The cheap headline prices are not for you
Conditions applyThis is the line worth carrying out of the room. The direct-to-consumer deals announced in November 2025 do nothing for someone buying through an insurance plan.
“It is important to note that these reduced prices apply only to direct-to-consumer purchases. The agreement does not affect pricing for individuals using non-Medicare insurance such as that offered by the Board.”
Wisconsin Department of Employee Trust Funds, Office of Strategic Health Policy — Correspondence Memorandum to the Group Insurance Board — February 16, 2026 (Revised)
What the final package was called
ContextOption C, presented to the board at its March meeting as one line among the plan-design changes.
“New $200 copay for GLP-1s for weight loss”
Wisconsin Department of Employee Trust Funds, Office of Strategic Health Policy — March 13, 2026
Which of these companies serve Wisconsin?
Of the 101 companies we grade, 12 publish a list of the states they are licensed in. We checked 86 more and found no such list on any page we read; 3 we have not checked either way.
8 of those lists name Wisconsin: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, Wisp, WePeptideRx and Ways2Well. That is a licensure claim each company makes about itself, not something we checked with a state board.
A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.
Sources
Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026, the same session as the rest of this page.
- GIB Approves Cost Sharing, GLP-1s for Weight Loss for 2027 — Wisconsin Department of Employee Trust Funds — Department News. the release date printed under the headline — the page carries a separate line reading "Updated: April 15, 2026", and that is a different fact from the release date, so it is not folded into one: March 16, 2026.
- 2027 Final Benefit and Contract Changes — Wisconsin Department of Employee Trust Funds, Office of Strategic Health Policy — Correspondence Memorandum to the Group Insurance Board. the "Date:" line in the memo header, printed with its "(Revised)" marker — the URL path reads 2026/02/25, which is the meeting, not the memo: February 16, 2026 (Revised).
- 2027 Final Benefit and Contract Changes — Item 1B, Group Insurance Board — Wisconsin Department of Employee Trust Funds, Office of Strategic Health Policy. the date printed in the running footer of every slide, which reads "2027 Benefit Changes Clarifications– March 13, 2026": March 13, 2026.
Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.
If you're paying cash instead
None of the above changes what a telehealth seller charges you. None of the 3 rows below carries both a medication price and a monthly fee we could capture, so no figure here is a sum. Each cell says what its number covers and what we could not confirm, and every number was read on the seller's own page.
NovoCare Pharmacy, Ro and Levity pay us nothing — none of the 3 below does. The buttons run through our own redirect so we can count the click, and counting is all they do.
| Grade | Provider | What a month actually costs | The one thing that matters here | Go to the provider |
|---|---|---|---|---|
| BMinor gap | NovoCare Pharmacy | $149a month, medication onlybrand Wegovy tablets 1.5 mgMedication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.Self-pay. One month is one bottle of 30 tablets.The lowest of the 9 medication prices we captured here | The drugmaker's own counter, and the one the board's memo quotes. Its $199 Wegovy pen is a two-fill introductory rate for new patients that becomes $349, which is the number to hold against a $200 copay. | See its prices at NovoCare Pharmacy (opens in a new tab)Pays us nothing |
| BMinor gap | Ro | $349a month, medication onlybrand semaglutideMedication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.Advertised at $199The lowest of the 2 medication prices we captured here | Wegovy runs $199 for the first two starter doses and $349 at the maintenance dose, with membership billed separately on top of both. | See its prices at Ro (opens in a new tab)Pays us nothing |
| CCaveat | Levity | $1,199a month, medication onlybrand OzempicMedication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.The cheapest of the three. First month $1,149 with a code.The lowest of the 3 medication prices we captured here | Sells branded pens at $1,199 to $1,599 a month with everything folded in, and publishes a real state list — though its own homepage advertises $129 to $179 in the hero above those figures. | See its prices at Levity (opens in a new tab)Pays us nothing |
Our grading method and how we verify a price explain what those letters mean and where these figures came from.